Newscenter Media News Elon Musk’s brain-chip startup, Neuralink, has received the US Food and Drug Administration’s “breakthrough device” designation for the company’s experimental implant, Blindsight. The device, called ‘Blindsight,’ is designed to restore vision in individuals with complete or partial blindness, including those with non-functional optic nerves. “We have received Breakthrough Device Designation from the FDA for Blindsight.
Check Also
Ogun community seeks relocation of dump, alleges health, security risks
Residents of the Yakoyo community in the Ojodu Abiodun area of Ifo Local Government Area …